Fundraising Fox
StimOxyGen
Belfast, GB · 3 known investors
Find your way into StimOxyGen
Sign up to see every warm intro you have to StimOxyGen
- Paths you didn't know you had: your email and LinkedIn already hold routes to the StimOxyGen team. We find them for you
- 2nd- and 3rd-degree connections: the friend-of-a-friend routes that take hours to manually find through your inbox or LinkedIn
- Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone
Days of research, done the moment you sign in, with every route ranked by how warm it is.
StimOxyGen develops advanced nanoparticle-based therapies using sonodynamic and oxygen-generating technology for oncology and wound healing. The company focuses on addressing unmet medical needs in cancer treatment and tissue regeneration.
Founders & leadership
S
SianChief Executive Officer, Co-founder
A
AnthonyChief Scientific Officer, Founder
Investors · 3
Companies House · registry record
View on Companies House ↗- Registered name
- STIMOXYGEN LTD
- Company number
- NI677236
- Status
- Active
- Company type
- Private limited company
- Incorporated
- 9 Mar 2021
- Registered office
- C/O A&L Goodbody Northern Ireland Llp, 42-46 Fountain Street, Belfast, BT1 5EF
- Nature of business (SIC)
- 32500 — Manufacture of medical and dental instruments and supplies72110 — Research and experimental development on biotechnology
- Accounts
- last made up to 31 Mar 2025 · next due 31 Dec 2026
- Confirmation statement
- last made up to 8 Mar 2026 · next due 22 Mar 2027
Current officers · 5
- Sarcon Compliance Limited — corporate secretary, appointed 9 Mar 2021
- Fergus Begley — director, appointed 7 Dec 2021
- Sian Farrell — director, appointed 9 Mar 2021
- Anthony Mchale — director, appointed 9 Mar 2021
- Leslie James Russell — director, appointed 9 Mar 2021
Source: Companies House public register · retrieved 9 Aug 2026. Contains public sector information licensed under the Open Government Licence v3.0.
In the news
Frequently asked questions
- What does StimOxyGen do?
- StimOxyGen develops advanced nanoparticle-based therapies using sonodynamic and oxygen-generating technology for oncology and wound healing. The company focuses on addressing unmet medical needs in cancer treatment and tissue regeneration.
- Who founded StimOxyGen?
- StimOxyGen was founded by Sian, Anthony.
- Who are StimOxyGen's investors?
- StimOxyGen's investors include Clarendon Fund Managers Ltd., DSW Ventures, Invest Northern Ireland.
- Where is StimOxyGen headquartered?
- StimOxyGen is headquartered in Belfast, GB.